Methods and compositions for treating amyloid-related diseases
4 Assignments
0 Petitions
Accused Products
Abstract
Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.
100 Citations
220 Claims
- 1. A compound of the formula (VIII):
-
2-16. -16. (canceled)
-
17. A compound of the formula (IX):
-
18-22. -22. (canceled)
-
23. A compound of the formula (X):
-
24-34. -34. (canceled)
-
35. A compound of the formula (XI):
-
36-42. -42. (canceled)
-
43. A compound of the formula (XII):
-
44-53. -53. (canceled)
-
54. A compound of the formula (XIII):
-
55-57. -57. (canceled)
-
58. A compound of the formula (XIV):
-
59. (canceled)
-
60. A compound of the formula (XV):
-
61. (canceled)
-
62. A compound of Table 3A or Table 3B, or a pharmaceutically acceptable salt, ester, or prodrug thereof.
-
69. (canceled)
-
71-75. -75. (canceled)
-
77-82. -82. (canceled)
-
84. (canceled)
-
89-181. -181. (canceled)
-
183-193. -193. (canceled)
-
195. (canceled)
-
197-204. -204. (canceled)
-
211-215. -215. (canceled)
-
219. A pharmaceutical composition comprising a compound selected from the group consisting of the compounds in Tables 3A and 3B and a pharmaceutically acceptable carrier.
Specification